Skip to content

Follow-up of the Patients Included in the EXESAS Study

Follow-up of the Patients Included in the EXESAS Study : Analysis of the Profit of the Physical Activity for the Control Group and of the Preservation of a Regular Physical Activity for the Group Initially Trained

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02920723
Acronym
FOLLOW_EXESAS
Enrollment
79
Registered
2016-09-30
Start date
2016-09-01
Completion date
2018-08-21
Last updated
2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnea, Obstructives, Sleep Apnea Syndromes

Keywords

Sleep Apnea Syndromes, Sleep Apnea, Obstructives, Training

Brief summary

Sleep apnoea affects more than 20% of people over 65 years and is largely underdiagnosed. It does multiply tenfold the occurrence of vascular events, particularly stroke. While Continuous Positive Airway Pressure (CPAP) is currently the Gold standard treatment to prevent cerebrovascular and cardiovascular events, with a major clinical benefit, long term adherence to CPAP is a significant problem and search for alternative treatment is essential.

Detailed description

In the previous EXESAS study (NCT02463890) the investigators compare evolution of Apnea Hypopnea Index (AHI) in an exercise trained group performed through in a national based non-profit organization (Fédération Française d'éducation Physique et de Gymnastique Volontaire (FFEPGV)) using a medical established program (NeuroGyV) during nine months against a control group receiving only standard dietetic and physical activity counseling. The first partial observations of the study EXESAS seem encouraging in the term of 3 months of training. However, in the longer term, there is not a coverage in the treatment of the moderate Sleep Apnea: Obstructive Syndrome (SAOS). Thus they can logically expect that the possible therapeutic effect of the exercise is not maintained in the long term after the stop of the training. This nex study suggests studying the profit of the exercise on sleep apneas for the patients who were initially in the control group in the EXESAS study and to observe if the preservation of a regular physical activity for the group which was trained in EXESAS study is associated with a preservation of the AHI after the additional year of follow-up without additional intervention

Interventions

OTHERTraining
OTHERControl

Sponsors

Centre Hospitalier Universitaire de Saint Etienne
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Included in the previous EXESAS study * Signature of consent

Exclusion criteria

* Patients being already treated for sleep apnea or clinical status (cardiovascular comorbidities) justifying an immediate initiation of CPAP * Daytime sleepiness (ESS score \> 10) * Known respiratory or heart disease (or discovering during stress test) contraindicated exercise training * Patients with Parkinson's disease * AHI \> 30

Design outcomes

Primary

MeasureTime frameDescription
the AHI (number of Apnea+Hypopnea per hour) through polysomnography assessment after twelve months of follow-up in the training and the control groups12 monthsApnea-Hypopnea Index (AHI)

Secondary

MeasureTime frameDescription
Percentage of patients with AHI<15 through polysomnography assessment after twelve months of follow-up in the training and the control groups.12 months
Change in high frequency (HF) of spectral analysis of heart rate variability (parasympathetic index) at 12 months of follow-up in the 2 groups12 months
Maximal aerobic capacity (VO2Max)12 monthsCorrelation between the change in VO2max during stress test, walking distance during 6 minutes and AHI in the two groups
Population Physical Activity questionnaire (POPAQ)12 monthsCorrelation between the change in daily physical activity energy expenditure (estimated by the POPAQ questionnaire) and AHI in the two groups
Percentage of patients with AHI>30 through polysomnography assessment after twelve months of follow-up in the training and the control groups.12 months
Epworth sleepiness Scale12 monthsComparison of the variation of Epworth Sleepiness Scale (ESS) after 12 months follow-up for the two groups
Pittsburgh questionnaire12 monthsComparison of the variation of Pittsburgh questionnaire after 12 months follow-up for the two groups
Berlin questionnaire12 monthsComparison of the variation of Berlin questionnaire after 12 months follow-up for the two groups
Changes in blood pressure - Baroreflex12 monthsMeasure of autonomic function (parasympathetic activity) - quantified via changes in blood pressure
Daily physical activity energy expenditure12 monthsCorrelation between the daily physical activity energy expenditure (estimated directly by an actimetry sensor for 7 days) and AHI in the two groups

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026